Bing Han
Impact in
- Hepatology top 5%
- Liver Disease and Transplantation
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 13
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Liver Disease and Transplantation 7
- Journals
- International Immunopharmacology (4 papers)Medicine (3 papers)Frontiers in Immunology (2 papers)Molecules (2 papers)Gut Microbes (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bing Han
119 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 159
- Hepatology 156
- Cancer Research 170
- Epidemiology 380
- Health Informatics 14
- Endocrinology, Diabetes and Metabolism 153
Countries citing papers authored by Bing Han
This map shows the geographic impact of Bing Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Han more than expected).
Fields of papers citing papers by Bing Han
This network shows the impact of papers produced by Bing Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Han. The network helps show where Bing Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bing Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 0 | |
| 15 | 2022 | 1 | |
| 16 | 2021 | 56 | |
| 17 | 2021 | 8 | |
| 18 | 2020 | 7 | |
| 19 | 2018 | 6 | |
| 20 | 2013 | 61 |
About Bing Han
Bing Han is a scholar working on Hepatology, Applied Microbiology and Biotechnology, Immunology and Allergy, Cancer Research and Dermatology, having authored 129 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (7 papers), Breast Cancer Treatment Studies (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Inflammatory Bowel Disease (4 papers), Allergic Rhinitis and Sensitization (4 papers) and Breast Lesions and Carcinomas (3 papers). The work is most often cited by research in Hepatology (156 citations), Cancer Research (170 citations), Epidemiology (380 citations), Health Informatics (14 citations) and Endocrinology, Diabetes and Metabolism (153 citations). Bing Han has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xingshun Qi, Miaomiao Li, Mei Zhu, Changwei Ma, Min Du, Tongwen Sun, Xianfei Ding, Xiaoguang Duan, Junfeng Tong and Yingxin Zhang. Their work appears in journals such as International Immunopharmacology, Medicine, Frontiers in Immunology, Molecules and Gut Microbes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.